A Clinical Study On Post Covid Stress Disorder And Its Homoeopathic Management

A Clinical Study On Post traumatic Stress Disorder in covid 19 And Its Homoeopathic Management

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041620

Enrollment

Registered

2022-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F431- Post-traumatic stress disorder (PTSD)

Interventions

Intervention1: Homoeopathic Medicine: Homoeopathic medicines are selected based on individualization and the range of the potency 30C 200C 1M 10M will be used of singel dose of indicated remedy and ad

Eligibility

Inclusion criteria

Inclusion criteria: Both male and female patient are included Age group 21 to 50 years

Exclusion criteria

Exclusion criteria: Patient with active treatment for any other chronic disease Patient with organic mental disorder

Design outcomes

Primary

Measure	Time frame
Diagnosis based on clinical presentation such as problems sleeping ,difficulties with concentration, angry outbursts, substance abuse Timepoint: At baseline and after 6 months	—

Secondary

Measure	Time frame
It is expected that the proposed study will be useful in reducing the symptoms of post traumatic stress disorderTimepoint: at baseline and after 6 months	—

Countries

India

Contacts

Public ContactDr K S LALITHAA

Vinayaka Missions Homoeopathic Medical College And Hospital

drlalithaagogul@gmail.com9940245577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026